These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Type C virus particles in X63-Ag8.653 mouse plasmacytoma cells and in hybridomas derived from it. Rudolph M; Karsten U; Micheel B Arch Geschwulstforsch; 1983; 53(6):513-9. PubMed ID: 6670912 [TBL] [Abstract][Full Text] [Related]
10. Optimization of electrofusion parameters for efficient production of murine hybridomas. Stenger DA; Kubiniec RT; Purucker WJ; Liang H; Hui SW Hybridoma; 1988 Oct; 7(5):505-18. PubMed ID: 3198135 [TBL] [Abstract][Full Text] [Related]
11. Improved fusion technique. II. Stability and purity of hybrid clones. Westerwoudt RJ; Naipal AM; Harrisson CM J Immunol Methods; 1984 Mar; 68(1-2):89-101. PubMed ID: 6538588 [TBL] [Abstract][Full Text] [Related]
12. Density separation of spleen cells increases fusion frequency and yield of Ig-producing hybridomas. Van Mourik P; Rivero RA; Van der Kwast TH; Lansdorp PM; Zeijlemaker WP J Immunol Methods; 1984 Mar; 68(1-2):45-53. PubMed ID: 6323584 [TBL] [Abstract][Full Text] [Related]
13. Colcemid treatment of myeloma prior to cell fusion increases the yield of hybridomas between myeloma and splenocyte. Miyahara M; Nakamura H; Hamaguchi Y Biochem Biophys Res Commun; 1984 Nov; 124(3):903-8. PubMed ID: 6508785 [TBL] [Abstract][Full Text] [Related]
14. High yields of specific hybridomas obtained by electrofusion of murine lymphocytes immunized in vivo or in vitro. van Duijn G; Langedijk JP; de Boer M; Tager JM Exp Cell Res; 1989 Aug; 183(2):463-72. PubMed ID: 2767160 [TBL] [Abstract][Full Text] [Related]
15. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells. Takahashi M; Fuller SA; Hurrell JG J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563 [TBL] [Abstract][Full Text] [Related]
16. Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas. Karsten U; Stolley P; Walther I; Papsdorf G; Weber S; Conrad K; Pasternak L; Kopp J Hybridoma; 1988 Dec; 7(6):627-33. PubMed ID: 3235098 [TBL] [Abstract][Full Text] [Related]
17. Development of microfusion techniques to generate human hybridomas. Foung S; Perkins S; Kafadar K; Gessner P; Zimmermann U J Immunol Methods; 1990 Nov; 134(1):35-42. PubMed ID: 2172386 [TBL] [Abstract][Full Text] [Related]
18. An improved electrofusion technique for production of mouse hybridoma cells. Vienken J; Zimmermann U FEBS Lett; 1985 Mar; 182(2):278-80. PubMed ID: 3979550 [TBL] [Abstract][Full Text] [Related]
19. Facilitated cell fusion for hybridoma production. Conrad MK; Lo MM Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431 [No Abstract] [Full Text] [Related]
20. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]